Stanford researchers have created a new strategy for collecting and integrating human microbiome, multi-omics, and immune cell activation data that reveals new insights into the roles of different bacterial strains in human health.
Stanford researchers have identified that increased oxidative stress is a key molecular signature of fatigue-based conditions including Long COVID and myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS).
Stanford inventors have developed an early-stage screening method to diagnose abdominal aortic aneurysms (AAA). AAA is a common cardiovascular disease with high prevalence in European men 65 years and above.
Stanford researchers at the Snyder Lab have developed a novel software application, called the Metabolic Subphenotype Predictor, which predicts if a patient is insulin resistant through continuous glucose monitoring.
Researchers at Stanford have developed synthetic transcription elongation factors (Syn-TEFs) to treat proliferative diseases, including repeat expansion mutations in cancer.
Stanford researchers at the Snyder Lab have developed a method for simultaneously measuring thousands of proteins, lipids, and metabolites from home-collected 10 ?L blood samples in conjunction with wearable sensors.
Stanford researchers developed a framework called 'Hummingbird' that predicts the cheapest, fastest and most efficient configurations to execute genomics pipelines on the cloud.
Researchers at Stanford have developed AgeIndex, the first whole-genome epigenetic aging index and method based on Whole Genome Bisulfite Sequencing (WGBS) assays.
Using their newly developed acetyl-click screening platform, researchers at Stanford have identified riboflavin analogs as small molecule inhibitors of Histone Acetyltransferase 1 (HAT1) with anti-cancer activity.
Stanford researchers in the Snyder lab have discovered and developed an innovative immunoglobulin modality for the treatment of insulin resistance and type 2 diabetes.
Stanford scientists have invented a method that can determine the gestational age of a fetus by testing the mother's urine using metabolomics profiling and machine learning.
Researchers at Stanford University have identified molecular regulators that can act as part of a personalized treatment plan to help treat hormone-related conditions, including pregnancy and infertility.
Histone acetyltransferase 1 (HAT1) is an enzyme which acetylates lysine on histone proteins and is intricately involved with regulating gene transcription.